Lansdowne Partners (Uk) LLP Illumina, Inc. Transaction History

Lansdowne Partners (Uk) LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$181.58 - $368.0 $9.34 Million - $18.9 Million	-51,444 Reduced 97.59%	1,271 $234,000
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $104 Million - $145 Million	-341,599 Reduced 86.63%	52,715 $18.4 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $8.56 Million - $10.4 Million	24,635 Added 6.66%	394,314 $150 Million
Q3 2021 Nov 12, 2021	BUY	$405.61 - $524.84 $56.7 Million - $73.4 Million	139,811 Added 60.82%	369,679 $150 Million
Q2 2021 Aug 13, 2021	BUY	$372.84 - $481.5 $85.7 Million - $111 Million	229,868 New	229,868 $109 Million

904

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Lansdowne Partners (Uk) LLP, based on Form 13F filings with the SEC.

Stay updated on Lansdowne Partners (Uk) LLP with notifications on news.